Probably the saddest thing about our lives is that everything comes to an end. A few days ago, sadly, one of the best things that happened to the internet ended. To be more specific, Maru, the most ...

A common artificial sweetener could make cancer treatments less effective, a new study has found. Sucralose, a sweetener found in many diet sodas, low-calorie snacks and powdered sugar substitutes, ...

Russia has reported that its cancer vaccine "Enteromix" has completed preclinical trials—demonstrating both safety and high efficacy. Veronika Skvortsova, head of the Russian Federal ...

Older individuals between the ages of 75 and 80 who are eligible for lung surgery may achieve survival outcomes comparable to younger patients following lung cancer screening, according to research ...

Crizotinib, an approved treatment for advanced ALK-positive (ALK+) non-small cell lung cancer (NSCLC), did not improve disease-free survival (DFS) when given as adjuvant therapy in patients with ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

The British government condemned the remarks, made without evidence by the cardiologist, Dr. Aseem Malhotra, at an event for the anti-immigration party led by Nigel Farage. By Stephen Castle Reporting ...

Abstract: Breast cancer poses a global health challenge for women, making early detection and precise classification crucial for successful treatment. The study presents Intelligent Data ...

Abstract: Since lung cancer has few symptoms and it might be difficult to spot lung nodules in medical imaging, prompt detection is essential to improving the survival rate of patients. Innovative, ...

US health secretary and ardent anti-vaccine activist Robert F. Kennedy Jr. went before the Senate Finance Committee on Thursday amid turmoil at the Centers for Disease Control and Prevention and ...

Eli Lilly has won a key U.S. Food and Drug Administration designation for its investigational drug olomorasib in certain lung cancer patients. Eli Lilly on Thursday said the FDA granted ...